Ozempic may lead to a lower loss of lean body mass compared to Mounjaro. This may be due to tirzepatide medications, like ...

GLP-1-based therapies helped adults with overweight or obesity lose weight mainly by reducing fat mass and visceral adipose ...

Altimmune said its experimental drug in a midstage trial helped patients shed weight but also minimized the loss of muscle mass. Altimmune is one of several smaller biotech companies pushing to ...

With increased usage of weight loss drugs such as semaglutide and tirzepatide many people see the scale move down but a less visible concern is emerging which is loss of metabolically active muscle ...

By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

After a full data analysis, Altimmune is heralding phase 2 obesity data for pemvidutide as “best-in-class” for spurring weight loss while preserving lean mass. The small biotech is going up against ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Some patient populations may be at higher risk for lean ...

As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.

Medically reviewed by Amelia MacIntyre, DO Key Takeaways Overweight and obesity both carry health risks, but body mass index ...

The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also ...